Patent: 10,301,376
✉ Email this page to a colleague
Summary for Patent: 10,301,376
Title: | Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
Abstract: | Provided are combinations, compositions and kits containing a immune globulin (IG) composition and a soluble hyaluronidase composition formulated for subcutaneous administration. Such products can be used in methods of treating IG-treatable diseases or conditions. Also provided are methods for subcutaneous administration of immune globulin whereby the dosing regimen is substantially the same as for intravenous administration of the same dosage for treatment of the same IG-treatable disease or condition. |
Inventor(s): | Schiff; Richard (Santa Rosa Valley, CA), Leibl; Heinz (Vienna, AT) |
Assignee: | Baxalta GmbH (Zug, CH) Baxalta Incorporated (Bannockburn, IL) |
Application Number: | 12/381,844 |
Patent Claims: | see list of patent claims |
Details for Patent 10,301,376
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | 05/05/2004 | ⤷ Try a Trial | 2028-03-17 |
Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | 12/02/2004 | ⤷ Try a Trial | 2028-03-17 |
Amphastar Pharmaceuticals, Inc. | AMPHADASE | hyaluronidase | Injection | 021665 | 10/26/2004 | ⤷ Try a Trial | 2028-03-17 |
Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | 10/25/2005 | ⤷ Try a Trial | 2028-03-17 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 05/21/2004 | ⤷ Try a Trial | 2028-03-17 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 03/26/2007 | ⤷ Try a Trial | 2028-03-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |